Trending Drug News Powered by Trendolizer

Psychedelic psilocybin therapy for depression granted Breakthrough Therapy status by FDA

Trending story found on newatlas.com
Psychedelic psilocybin therapy for depression granted Breakthrough Therapy status by FDA
The FDA has given psilocybin therapy for treatment-resistant depression a Breakthrough Therapy status. This classification suggests the treatment has demonstrated significant potential in early clinical evidence, allowing the FDA to assist and expedite subsequent development and review processes.
[Source: newatlas.com] [ Comments ] [See why this is trending]

Trend graph:

Comments